NCT06891209 Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
| NCT ID | NCT06891209 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Bladder Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-01-15 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study explores and compares health-related quality of life and urinary outcomes in postoperative partial cystectomy and matched radical cystectomy patients.
Eligibility Criteria
Inclusion Criteria: * Currently living partial cystectomy patients in Mayo Urology's cystectomy registry and patients undergoing radical or partial cystectomy * Matched 2:1 living radical cystectomy to partial cystectomy patients * Either urothelial or non-urothelial histology Exclusion Criteria: * Partial cystectomy patients that underwent subsequent radical cystectomy
Contact & Investigator
Vidit Sharma, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06891209 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06891209 currently recruiting?
Yes, NCT06891209 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06891209 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06891209 clinical trial?
NCT06891209 is sponsored by Mayo Clinic. The principal investigator is Vidit Sharma, MD at Mayo Clinic. The trial plans to enroll 1,000 participants.